Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zexian Wang
Institution:
Xuzhou Medical College
Observed institution:
Xuzhou Medical College
ORCID:
0009-0002-5890-4275
Observed ORCID:
0009-0002-5890-4275
OpenAlex ID:
A5071100902
Bevacizumab Plus EGFR-TKIs vs EGFR-TKIs Alone for Advanced EGFR-Mutant NSCLC: A Meta-Analysis
2026
·
Zexian Wang
, Yaru Guo
, et al.
·
Clinical Medicine Insights Oncology
Chemotherapy plus Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor versus EGFR-TKI alone for advanced EGFR-mutant non-small cell lung cancer: a meta-analysis of randomized clinical trials
2024
·
Xiaohan Qin
, Yaru Guo
, et al.
PDF
Bevacizumab plus Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor versus EGFR-TKI alone for advanced EGFR-mutant non-small cell lung cancer: a meta-analysis of randomized clinical trials
2023
·
Zexian Wang
, Yaru Guo
, et al.
PDF
Show more works
View as search
Works count:
3
Citation count:
H-index:
I10-index:
Year
Topic
Type